Pulmonary functional imaging using hyperpolarized noble gas mri. Six years of start-up experience at a single site

Academic Radiology

Volumn 20, Issue 11, 2013, Pages 1344-1356

  Kirby, Miranda ^a,b   Parraga, Grace ^a,b,c,d  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b Department of Medical Biophysics ^*  (Canada)

^c Graduate Program in Biomedical Engineering   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Hyperpolarized helium 3; Lung disease; Magnetic resonance imaging

Indexed keywords

HELIUM; HELIUM 3; INERT GAS; UNCLASSIFIED DRUG; XENON; XENON 129;

ARTICLE; BIOTECHNOLOGICAL PROCEDURES; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEASIBILITY STUDY; FORCED EXPIRATORY VOLUME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERPOLARIZATION; LUNG DISEASE; LUNG FUNCTION; MEDICAL RESEARCH; MEDICAL STUDENT; MOTIVATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; POLARIMETER; PRIORITY JOURNAL; PULSE OXIMETRY; SCREENING; SPATIOTEMPORAL ANALYSIS; VELOCITY;

HYPERPOLARIZED HELIUM-3; LUNG DISEASE; MAGNETIC RESONANCE IMAGING;

HELIUM; HUMANS; LUNG DISEASES; MAGNETIC RESONANCE IMAGING; XENON;

EID: 84885343833     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2013.02.020     Document Type: Article

References (69)

1. Bergin C.J., Glover G.M., Pauly J. Magnetic resonance imaging of lung parenchyma. J Thorac Imaging 1993, 8:12-17.
2. Muller N.L., Mayo J.R., Zwirewich C.V. Value of MR imaging in the evaluation of chronic infiltrative lung diseases: comparison with CT. AJR Am J Roentgenol 1992, 158:1205-1209.
3. Mayo J.R., MacKay A., Muller N.L. MR imaging of the lungs: value of short TE spin-echo pulse sequences. AJR Am J Roentgenol 1992, 159:951-956.
4. Deimling M, Jellus V, Geiger B etal. Time resolved lung ventilation imaging by Fourier decomposition. Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Canada, 2639. 08. Abstract.
5. Bauman G., Scholz A., Rivoire J., et al. Lung ventilation- and perfusion-weighted Fourier decomposition magnetic resonance imaging: invivo validation with hyperpolarized (3) He and dynamic contrast-enhanced MRI. Magn Reson Med 2013, 69:229-237.
6. Bauman G., Lutzen U., Ullrich M., et al. Pulmonary functional imaging: qualitative comparison of Fourier decomposition MR imaging with SPECT/CT in porcine lung. Radiology 2011, 260:551-559.
7. Bauman G., Puderbach M., Deimling M., et al. Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI. Magn Reson Med 2009, 62:656-664.
8. Edelman R.R., Hatabu H., Tadamura E., et al. Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging. Nat Med 1996, 2:1236-1239.
9. Chen Q., Jakob P.M., Griswold M.A., et al. Oxygen enhanced MR ventilation imaging of the lung. MAGMA 1998, 7:153-161.
10. Stock K.W., Chen Q., Morrin M., et al. Oxygen-enhanced magnetic resonance ventilation imaging of the human lung at 0.2 and 1.5 T. J Magn Reson Imaging 1999, 9:838-841.
11. Loffler R., Muller C.J., Peller M., et al. Optimization and evaluation of the signal intensity change in multisection oxygen-enhanced MR lung imaging. Magn Reson Med 2000, 43:860-866.
12. Ohno Y., Hatabu H., Takenaka D., et al. Oxygen-enhanced MR ventilation imaging of the lung: preliminary clinical experience in 25 subjects. AJR Am J Roentgenol 2001, 177:185-194.
13. Muller C.J., Schwaiblmair M., Scheidler J., et al. Pulmonary diffusing capacity: assessment with oxygen-enhanced lung MR imaging preliminary findings. Radiology 2002, 222:499-506.
14. Ohno Y., Hatabu H., Takenaka D., et al. Dynamic oxygen-enhanced MRI reflects diffusing capacity of the lung. Magn Reson Med 2002, 47:1139-1144.
15. Ohno Y., Koyama H., Yoshikawa T., et al. Comparison of capability of dynamic O(2)-enhanced MRI and quantitative thin-section MDCT to assess COPD in smokers. Eur J Radiol 2012, 81:1068-1075.
16. Ohno Y., Koyama H., Matsumoto K., et al. Oxygen-enhanced MRI vs. quantitatively assessed thin-section CT: pulmonary functional loss assessment and clinical stage classification of asthmatics. Eur J Radiol 2011, 77:85-91.
17. Ohno Y., Iwasawa T., Seo J.B., et al. Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 177:1095-1102.
18. Ohno Y., Koyama H., Nogami M., et al. Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional loss assessment and clinical stage classification of smoking-related COPD. AJR Am J Roentgenol 2008, 190:W93-W99.
19. Jakob P.M., Wang T., Schultz G., et al. Assessment of human pulmonary function using oxygen-enhanced T(1) imaging in patients with cystic fibrosis. Magn Reson Med 2004, 51:1009-1016.
20. Kauczor H.U., Ebert M., Kreitner K.F., et al. Imaging of the lungs using 3He MRI: preliminary clinical experience in 18 patients with and without lung disease. J Magn Reson Imaging 1997, 7:538-543.
21. de Lange E.E., Mugler J.P., Brookeman J.R., et al. Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. Radiology 1999, 210:851-857.
22. Moller H.E., Chen X.J., Saam B., et al. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 2002, 47:1029-1051.
23. Albert M.S., Cates G.D., Driehuys B., et al. Biological magnetic resonance imaging using laser-polarized 129Xe. Nature 1994, 370:199-201.
24. Mugler J.P., Driehuys B., Brookeman J.R., et al. MR imaging and spectroscopy using hyperpolarized 129Xe gas: preliminary human results. Magn Reson Med 1997, 37:809-815.
25. Mugler JP, III, Mata JF, Wang HTJ, etal. The apparent diffusion coefficient of 129-Xe in the lung: preliminary human results. Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 769. 04. Abstract.
26. Sindile A, Muradian I, Hrovat M etal. Human pulmonary diffusion weighted imaging at 0.2T with hyperpolarizd 129Xe. Proceedings of the 15th Annual Meeting of ISMRM, Berlin, Germany, 1290. 07. Abstract.
27. Patz S., Hersman F.W., Muradian I., et al. Hyperpolarized (129)Xe MRI: aviable functional lung imaging modality?. Eur J Radiol 2007, 64:335-344.
28. Patz S., Muradian I., Hrovat M.I., et al. Human pulmonary imaging and spectroscopy with hyperpolarized 129Xe at 0.2T. Acad Radiol 2008, 15:713-727.
29. Cleveland Z.I., Cofer G.P., Metz G., et al. Hyperpolarized Xe MR imaging of alveolar gas uptake in humans. PLoS One 2010, 5:e12192.
30. Mugler J.P., Altes T.A., Ruset I.C., et al. Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129. Proc Natl Acad Sci U S A 2010, 107:21707-21712.
31. Kaushik S.S., Cleveland Z.I., Cofer G.P., et al. Diffusion-weighted hyperpolarized 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease. Magn Reson Med 2011, 65:1154-1165.
32. Dregely I., Mugler J.P., Ruset I.C., et al. Hyperpolarized Xenon-129 gas-exchange imaging of lung microstructure: first case studies in subjects with obstructive lung disease. J Magn Reson Imaging 2011, 33:1052-1062.
33. Driehuys B., Martinez-Jimenez S., Cleveland Z.I., et al. Chronic obstructive pulmonary disease: safety and tolerability of hyperpolarized 129Xe MR imaging in healthy volunteers and patients. Radiology 2012, 262:279-289.
34. Dregely I., Ruset I.C., Mata J.F., et al. Multiple-exchange-time xenon polarization transfer contrast (MXTC) MRI: initial results in animals and healthy volunteers. Magn Reson Med 2012, 67:943-953.
35. Driehuys B., Cofer G.P., Pollaro J., et al. Imaging alveolar-capillary gas transfer using hyperpolarized 129Xe MRI. Proc Natl Acad Sci U S A 2006, 103:18278-18283.
36. Lutey B.A., Lefrak S.S., Woods J.C., et al. Hyperpolarized 3He MR imaging: physiologic monitoring observations and safety considerations in 100 consecutive subjects. Radiology 2008, 248:655-661.
37. Ruset I.C., Ketel S., Hersman F.W. Optical pumping system design for large production of hyperpolarized. Phys Rev Lett 2006, 96:053002.
38. Hersman F.W., Ruset I.C., Ketel S., et al. Large production system for hyperpolarized 129Xe for human lung imaging studies. Acad Radiol 2008, 15:683-692.
39. Driehuys B., Pollaro J., Cofer G.P. Invivo MRI using real-time production of hyperpolarized 129Xe. Magn Reson Med 2008, 60:14-20.
40. Dregely I., Mugler J.P., Ruset I.C., et al. Hyperpolarized Xenon-129 gas-exchange imaging of lung microstructure: first case studies in subjects with obstructive lung disease. J Magn Reson Imaging 2011, 33:1052-1062.
41. Honda N., Osada H., Watanabe W., et al. Imaging of ventilation with dual-energy CT during breath hold after single vital-capacity inspiration of stable xenon. Radiology 2012, 262:262-268.
42. Chae E.J., Seo J.B., Goo H.W., et al. Xenon ventilation CT with a dual-energy technique of dual-source CT: initial experience. Radiology 2008, 248:615-624.
43. Carlson A.P., Brown A.M., Zager E., et al. Xenon-enhanced cerebral blood flow at 28% xenon provides uniquely safe access to quantitative, clinically useful cerebral blood flow information: a multicenter study. AJNR Am J Neuroradiol 2011, 32:1315-1320.
44. Suga K. Technical and analytical advances in pulmonary ventilation SPECT with xenon-133 gas and Tc-99m-Technegas. Ann Nucl Med 2002, 16:303-310.
45. Shukla Y., Wheatley A., Kirby M., et al. Hyperpolarized (129)xe magnetic resonance imaging: tolerability in healthy volunteers and subjects with pulmonary disease. Acad Radiol 2012, 19:941-951.
46. Reis S, Ruppert K, Altes TA etal. Hyperpolarized Xe-129 CSI of the human lung: preliminary results from healthy, second-hand smoker and cystic fibrosis subjects. Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 629. 12. Ref Type: Abstract.
47. Shukla Y., Wheatley A., Kirby M., et al. Hyperpolarized 129Xe magnetic resonance imaging: tolerability in healthy volunteers and subjects with pulmonary disease. Acad Radiol 2012, 19:941-951.
48. Altes T.A., Powers P.L., Knight-Scott J., et al. Hyperpolarized 3He MR lung ventilation imaging in asthmatics: preliminary findings. J Magn Reson Imaging 2001, 13:378-384.
49. Mathew L., Kirby M., Etemad-Rezai R., et al. Hyperpolarized (3)He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. Eur J Radiol 2011, 79:140-146.
50. Kirby M., Mathew L., Wheatley A., et al. Chronic obstructive pulmonary disease: longitudinal hyperpolarized (3)He MR imaging. Radiology 2010, 256:280-289.
51. Mathew L., Gaede S., Wheatley A., et al. Detection of longitudinal lung structural and functional changes after diagnosis of radiation-induced lung injury using hyperpolarized 3He magnetic resonance imaging. Med Phys 2010, 37:22-31.
52. Mathew L., Evans A., Ouriadov A., et al. Hyperpolarized 3He magnetic resonance imaging of chronic obstructive pulmonary disease: reproducibility at 3.0 tesla. Acad Radiol 2008, 15:1298-1311.
53. Parraga G., Mathew L., Etemad-Rezai R., et al. Hyperpolarized 3He magnetic resonance imaging of ventilation defects in healthy elderly volunteers: initial findings at 3.0 Tesla. Acad Radiol 2008, 15:776-785.
54. Parraga G., Ouriadov A., Evans A., et al. Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol 2007, 42:384-391.
55. Woodhouse N., Wild J.M., Paley M.N., et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magn Reson Imaging 2005, 21:365-369.
56. de Lange E.E., Altes T.A., Patrie J.T., et al. The variability of regional airflow obstruction within the lungs of patients with asthma: assessment with hyperpolarized helium-3 magnetic resonance imaging. J Allergy Clin Immunol 2007, 119:1072-1078.
57. de Lange E.E., Altes T.A., Patrie J.T., et al. Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest 2006, 130:1055-1062.
58. de Lange E.E., Altes T.A., Patrie J.T., et al. Changes in regional airflow obstruction over time in the lungs of patients with asthma: evaluation with 3He MR imaging. Radiology 2009, 250:567-575.
59. Mentore K., Froh D.K., de Lange E.E., et al. Hyperpolarized HHe 3 MRI ofthe lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol 2005, 12:1423-1429.
60. Altes T.A., Rehm P.K., Harrell F., et al. Ventilation imaging of the lung: comparison of hyperpolarized helium-3 MR imaging with Xe-133 scintigraphy. Acad Radiol 2004, 11:729-734.
61. Fain S.B., Gonzalez-Fernandez G., Peterson E.T., et al. Evaluation of structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI. Acad Radiol 2008, 15:753-762.
62. Lee E.Y., Sun Y., Zurakowski D., et al. Hyperpolarized 3He MR imaging of the lung: normal range of ventilation defects and PFT correlation in young adults. J Thorac Imaging 2009, 24:110-114.
63. Kirby M., Heydarian M., Svenningsen S., et al. Hyperpolarized (3)he magnetic resonance functional imaging semiautomated segmentation. Acad Radiol 2012, 19:141-152.
64. Tustison N.J., Avants B.B., Flors L., et al. Ventilation-based segmentation of the lungs using hyperpolarized (3)He MRI. J Magn Reson Imaging 2011, 34:831-841.
65. Tustison N.J., Altes T.A., Song G., et al. Feature analysis of hyperpolarized helium-3 pulmonary MRI: a study of asthmatics versus nonasthmatics. Magn Reson Med 2010, 63:1448-1455.
66. Kirby M., Mathew L., Heydarian M., et al. Chronic obstructive pulmonary disease: quantification of bronchodilator effects by using hyperpolarized (3)He MR imaging. Radiology 2011, 261:283-292.
67. Costella S., Kirby M., Maksym G.N., et al. Regional pulmonary response to a methacholine challenge using hyperpolarized (3) He magnetic resonance imaging. Respirology 2012, 17:1237-1246.
68. Kirby M., Kanhere N., Etemad-Rezai R., et al. Hyperpolarized helium-3 magnetic resonance imaging of chronic obstructive pulmonary disease exacerbation. J Magn Reson Imaging 2012, 37:1223-1227.
69. de Lange E.E., Altes T.A., Patrie J.T., et al. The variability of regional airflow obstruction within the lungs of patients with asthma: assessment with hyperpolarized helium-3 magnetic resonance imaging. J Allergy Clin Immunol 2007, 119:1072-1078.